RxDoctor Payments Data

Amber Lopez, APRN

Primary Care · Knoxville, TNNPI 1154674430

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations.

$2,620in general payments, 2019–2025

Across 142 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$470
  • Johnson & Johnson$343
  • Takeda Pharmaceuticals U.S.A., Inc.$298
  • Madrigal Pharmaceuticals$237
  • Phathom Pharmaceuticals, Inc.$225
  • Ardelyx, Inc.$186
  • plus $862 from 13 others

What the payments were for

  • Food & beverage$2,620100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,620 in reported general payments places this provider in the 80th percentile of 189 primary care providers in Tennessee.

See all primary care providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,023
Medicare patients
32
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,889
Atomoxetine Hcl12$2,275
Clonidine Hcl ErClonidine Hcl21$1,247
Levothyroxine Sodium91$1,230
Albuterol Sulfate HfaAlbuterol Sulfate16$860
Metformin Hcl ErMetformin Hcl69$800
Celecoxib15$771
Midodrine Hcl13$616
Sumatriptan Succinate16$589
Atorvastatin Calcium82$585
Pioglitazone Hcl11$566
Famotidine32$529
Propranolol Hcl19$353
Omeprazole43$333
Metoprolol Succinate22$309

Paid to pharmacies, not to this prescriber.

Other primary care in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →